CN105853668A - Medicament for treating lumbar disc herniation, osteoporosis and cervical spondylosis - Google Patents
Medicament for treating lumbar disc herniation, osteoporosis and cervical spondylosis Download PDFInfo
- Publication number
- CN105853668A CN105853668A CN201610336320.3A CN201610336320A CN105853668A CN 105853668 A CN105853668 A CN 105853668A CN 201610336320 A CN201610336320 A CN 201610336320A CN 105853668 A CN105853668 A CN 105853668A
- Authority
- CN
- China
- Prior art keywords
- parts
- osteoporosis
- medicament
- cervical spondylosis
- kidney
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
- A61K36/296—Epimedium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
Abstract
The invention discloses a medicament for treating lumbar disc herniation, osteoporosis and cervical spondylosis. The medicament consists of the following raw materials in parts by weight: 8 to 10 parts of angelica sinensis, 10 to 12 parts of ligusticum wallichii, 8 to 10 parts of white paeony root, 13 to 15 parts of kudzu vine root, 5 to 6 parts of cassia twig, 12 to 15 parts of earthworm, 13 to 15 parts of astragalus membranaceus, 12 to 15 parts of radix pseudostellariae, 15 to 16 pats of rhizoma cibotii, 14 to 15 parts of epimedium herb, 15 to 16 parts of Chinese yam, and 4 to 5 parts of carthamus tinctorius. The medicament is prepared by selecting the materials by giving the priority to tonify the liver and kidney and giving consideration to the treatment methods of invigorating qi, enriching blood, activating blood and removing blood stasis and the like according to the theories in traditional Chinese medicine that the lumbus is the seat of kidney, muscles are as important as bones, and the kidney leads the bones to generate marrow. Experiments in clinical medicine and in vivo and in vitro of animals show that the medicament for treating the lumbar disc herniation, the osteoporosis and the cervical spondylosis disclosed by the invention can reduce inflammatory factors and regulate bone metabolism fundamentally and enables the bone metabolism to convert to a positive balance direction.
Description
Technical field
The present invention relates to medicine, a kind of medicine treating prolapse of lumbar intervertebral disc, osteoporosis, cervical spondylosis.
Background technology
Prolapse of lumbar intervertebral disc and cervical spondylosis are mainly by intervertebral disc degeneration, and hyperosteogeny and wound, strain or congenital osteodysplasty etc. cause organizational structure dysequilibrium inside and outside spinal column, stimulate or vascular compression, neural, spinal cord and the series of symptoms that produces.Along with the prolongation of average human life, social senilization and the change of labor life mode, intervertebral disc degeneration phenomenon is significantly improved than before, it has also become impact is blue or green, in, common complaint among the elderly, frequently-occurring disease, and age of onset tends to become younger.Scholarly forecast, in the future 50 years of the beginning of this century to mid-term, the degeneration of intervertebral disc will become a kind of modern disease that modern society accompanies.There is no preferable medicine at present to treat, primary treatments has: 1, No operation: traction, acupuncture, acupoint injection therapy, physiotherapy, small needle knife, but it is the longest to hold time, and patient need to treat repeatedly；2, operation: window, resection of nucleus pulposus, radio-frequency (RF) ablation, though comparitive study is certainly, but consumption height, have certain traumatic, the more difficult acceptance of patient.
Bone is a kind of Biocomposite material, is made up of the support of bone organic gel fibril network structure, and inorganic matter calcium, phosphorus are filled in wherein.Osteoporosis is to be reduced to principal character, osseous tissue microstructure degenerative change with general bone amount, and declines and an osteoid metabolic disease of risk of fractures rising with the increase of sclerotin fragility, mechanical strength.Osteoporosis divides two classes: a class refers mainly to the female patient in menopause 15-20, and now porous spot is based on spinal vertebral and the spongy bone in extremities joint portion, accounts for about the 70% of this disease sum；The masculinity and femininity gerontal patient that two classes were primarily referred to as on 70 years old, now cortical bone also loosens, bone brittleness, thinning, and pulp cavity caliber increases, and accounts for the 30% of sum.Female postmenopausal osteoporosis refers to ovarian function failure, decrease in estrogen, secondary hyperthyroidism, calcitonin hyposecretion, thus causes bone resorption to be more than bone formation, occurs with the microstructure degenerative change of Low BMD and osseous tissue being its feature.Women postmenopausal osteoporotic patients, about China about 75,000,000 people, about the whole world 2.5 hundred million people, there is no preferable medicine at present to treat, primary treatments has: 1, controversies in hormone replacement in the elderly, need life-time service more than 7 years, determined curative effect, but have the severe complications such as carcinogenic rate and the metrorrhagia of 10%；2, calcium preparation and the use of fluoride preparation, can improve the density of bone, but because not improving the metabolism of bone, increase the fragility of bone on the contrary;3, the use of phosphate reagent, it can suppress osteoclast activity, but can not promote skeletonization.
Summary of the invention
It is an object of the invention to provide a kind of determined curative effect, have no side effect, pure Chinese herbal medicine treatment prolapse of lumbar intervertebral disc, osteoporosis, the medicine of cervical spondylosis.
Treatment prolapse of lumbar intervertebral disc, osteoporosis, the medicine of cervical spondylosis of the present invention, is made up of following weight parts raw material: Radix Angelicae Sinensis 8-10, Rhizoma Chuanxiong 10-12, Radix Paeoniae Alba 8-10, Radix Puerariae 13-15, Ramulus Cinnamomi 5-6, Pheretima 12-15, Radix Astragali 13-15, Radix Pseudostellariae 12-15, Rhizoma Cibotii 15-16, Herba Epimedii 14-15, Rhizoma Dioscoreae 15-16, Flos Carthami 4-5.
The treatment prolapse of lumbar intervertebral disc of the present invention, osteoporosis, the medicine of cervical spondylosis can be prepared as common drug dosage form by formulation method routinely.
The treatment treatment prolapse of lumbar intervertebral disc of the present invention, osteoporosis, the process for preparing medicine of cervical spondylosis are to choose raw material by above-mentioned composition, screen, clean, concoct, be dried, pulverize, sieve, make granule or decoction.
The property of medicine of each component raw material in the medicine treating prolapse of lumbar intervertebral disc, osteoporosis, cervical spondylosis of the present invention:
Radix Angelicae Sinensis: GUIXIN, liver, spleen channel.Replenishing and activating blood, menstruction regulating and pain relieving, loosening bowel to relieve constipation；For blood deficiency and yellow complexion, dizziness cardiopalmus, menoxenia, amenorrhea dysmenorrhea, asthenia cold abdominalgia, dryness of the intestine constipation, rheumatic arthralgia, injury from falling down, ulcer sores.
Rhizoma Chuanxiong: return liver, gallbladder, pericardium channel.Blood-activating and qi-promoting, wind-expelling pain-stopping.For menoxenia, amenorrhea dysmenorrhea, abdominal mass stomachache, breast side of body twinge, tumbling and swelling, headache, rheumatic arthralgia, numb limbs and tense tendons.
The Radix Paeoniae Alba: return liver, spleen channel, nourishing blood for regulating menstruation, suppressing the hyperactive liver pain relieving, astringing YIN to stop sweating；Have a menoxenia of heat for blood deficiency or the deficiency of YIN, metrorrhagia, deficiecny of liver-YIN, depression of liver-QI or the most high headache of liver-yang, dizziness, association's rib pain, wrist abdomen spasm of the limbs are had a pain, night sweat due to yin deficiency, and the exterior deficiency of disharmony of nutrient QI with defensive QI is from sweating syndrome.
Radix Puerariae: return spleen, stomach warp, expelling pathogenic factors from muscles for reducing heat, treating measles, promoting the production of body fluid to quench thirst, yang invigorating antidiarrheal；For fever caused by exogenous pathogens, have a headache stiffness of the nape, measles without adequate eruption, calentura excessive thirst, interior-heat is quenched one's thirst, diarrhea of heat type hematodiarrhoea, insufficiency of the spleen chronic diarrhea.
Ramulus Cinnamomi: GUIXIN, lung, bladder warp.Diaphoresis expelling pathogenic factors from muscles, warming the meridian and promoting blood circulation, activating YANG and prormoting functioning of QI；For affection of exogenous wind-cold exterior syndrome, the arthromyodynia of congealing cold with blood stasis, wrist abdomen cold type of pain, dysmenorrhea, amenorrhea, the thoracic obstruction, phlegm retention, edema and severe palpitation, irregularly intermittent and regularly intermittent pulse.
Pheretima: return liver, spleen, bladder warp, clearing heat for calming endogenous wind, dredging collateral, relieving asthma, diuresis；For hyperpyrexia convulsion, demented, blood stagnancy due to deficiency of QI, hemiplegia, lung-heat asthma, pyrolysis bladder, dysuria or urine retention are obstructed.
The Radix Astragali: returning spleen, lung meridian, tonifying Qi and lifting yang, benefit is defended consolidating superficial resistance, inducing diuresis to remove edema, held in the palm skin ulcer granulation promoting；For all cards of deficiency of spleen-QI and stomach-QI and sinking of QI of middle-JIAO, insufficiency of lung-QI and exterior deficiency spontaneous perspiration; the wet edema losing fortune of all cards of deficiency of vital energy diseases caused by exogenous pathogenic factor, deficiency of vital energy water; dysuria, insufficiency of vital energy and blood; difficulty in discharging of pus that skin infection caves in or burst is not held back for a long time, deficiency of qi and blood; shallow complexion; refreshing tired deficient pulse, the deficiency of vital energy can not take the photograph having blood in stool of blood, not all right arthralgia, numb limbs and tense tendons or the hemiplegia of metrorrhagia, blood stagnancy due to deficiency of QI, the diabete of deficiency of vital energy body fluid deficiency.
Radix Pseudostellariae: return spleen, lung meridian, tonifying QI to produce body fluid.For deficiency-weakness of spleen-QI, the lack of appetite asthenia of deficiency of stomach-Yin, the deficiency of the lung cough caused by dryness of deficiency of vital energy Tianjin wound and cardiopalmus sleeplessness, deficiency-heat hyperhidrosis.
Rhizoma Cibotii: return liver, kidney channel, invigorating the liver and kidney, except rheumatism, be good for waist foot, profit joint；Cure mainly lumbago, rheumatism, frequent micturition, seminal emission, leukorrhagia, hemorrhage.
Herba Epimedii: return liver, kidney channel, warming the kidney to invigorate YANG, bone and muscle strengthening, wind-damp dispelling；For the sexual impotence of insufficiency of kidney-YANG, infertile and frequent micturition, the myalgia of deficiency of the liver and kindey, rheumatism contracture is numb.
Rhizoma Dioscoreae: return spleen, lung, kidney channel, supplementing QI and nourishing YIN, spleen reinforcing lung kidney, treating spontaneous emission and leukorrhagia；Suffer from a deficiency of the kidney weak card, yin asthenia generating intrinsic heat for weakness of the spleen and stomach, lung, thirsty polydipsia, the diabete of frequent micturition.
Flos Carthami: GUIXIN, Liver Channel, latus rectum of invigorating blood circulation, eliminating stasis to stop pain；For amenorrhea, dysmenorrhea, lochia, lump in the abdomen mass in the abdomen, traumatic injury.
Treatment prolapse of lumbar intervertebral disc, osteoporosis, the medicine of cervical spondylosis of the present invention, theory according to the traditional Chinese medical science " waist is house of kidney " " muscles and bones is laid equal stress on " " the kidney generating marrow and dominating bone ", based on liver and kidney tonifying, take into account QI invigorating, enrich blood, the method for the treatment of such as blood circulation promoting and blood stasis dispelling, selected medicine is formulated.Wherein Rhizoma Cibotii, the Radix Astragali are monarch drug, and Herba Epimedii, Rhizoma Dioscoreae, Radix Pseudostellariae, Radix Puerariae, Rhizoma Chuanxiong, Pheretima are ministerial drug, and Radix Angelicae Sinensis, the Radix Paeoniae Alba, Flos Carthami are adjuvant drug, and Ramulus Cinnamomi is for making medicine, guiding drug.Chinese medicine meridian theory shows that bladder meridian this arteries and veins of keeping straight on walks at occipital bone respectively backward from head, enter cranial cavity, network brain, returning back out and go downwards to top respectively, lower guild is in DAZHUI acupoint, then divides left and right along inside omoplate, spinal column both sides, arrive waist, enter the muscle of spinal column both sides, go deep into body cavity, network kidney, belong to bladder.Compatibility is based on Chinese medicine " organic conception " and the big rule of " treatment of disease must aim at its pathogenesis " two.
The treatment prolapse of lumbar intervertebral disc of the present invention, osteoporosis, the medicine of cervical spondylosis, through clinical practice for many years, show determined curative effect, from 2,010 2014 years, with we's Drug therapy prolapse of lumbar intervertebral disc, cervical spondylosis, female postmenopausal osteoporosis, and set matched group comparison, its prolapse of lumbar intervertebral disc, cervical spondylosis, in osteoporosis, therapeutic component is not 100 examples, 110 examples, 121 examples, matched group 99 example, 108 examples, 118 examples, wherein prolapse of lumbar intervertebral disc, cervical spondylosis, three groups of cases of osteoporosis were all 1 course for the treatment of with 1 month, available 1-6 the course for the treatment of, Chinese medicine is decocted in water for oral dose every day 1 dose, 2 decoct 2 takes each extracting juice 150ml, clothes by several times.Prolapse of lumbar intervertebral disc, the efficacy assessment standard of cervical spondylosis: (1) is effective: clinical symptoms all disappears, recover normal activity function；(2) effective: clinical symptoms major part disappears, may occur in which the symptom of small part fiber crops；(3) invalid: main clinic symptoms, sign, movable function are without improving or increasing the weight of.The efficacy assessment standard of osteoporosis: (1) is effective: clinical symptoms all disappears, recovers normal activity function, union of fracture or compression pyramidal portion and recovers；(2) effective: clinical symptoms major part disappears, union of fracture or delayed union, Vertebral Compression is without increasing the weight of, and osteoporosis is improved, and recovers daily routines；(3) invalid: main clinic symptoms, sign, movable function and osteoporosis are without improving or increasing the weight of.Therapeutic outcome: treatment group is effective is respectively 78 examples, 92 examples, 78 examples, and effective 15 examples, 10 examples, 26 examples, invalid 7 examples, 8 examples, 17 examples, total effective rate is respectively 93%, 92.7%, 86%；Effective 45 examples of matched group, 54 examples, 41 examples, effective 26 examples, 32 examples, 34 examples, invalid 28 examples, 22 examples, 43 examples, total effective rate 71.7%, 79.6%, 63.3%.In prolapse of lumbar intervertebral disc, cervical spondylosis, osteoporosis, respective two groups of total effective rates compare, and there were significant differences (P < 0.01) to have notable difference (P < 0.01), two groups of obvious effective rates to compare.Above case follows up a case by regular visits to 1-5, and prolapse of lumbar intervertebral disc, treatment of cervical spondylopathy group only have prolapse of lumbar intervertebral disc 2 example recurrences occur, and the recurrence of more than 5 examples all occurs in matched group；None example generation refracture of osteoporosis treatment group.Matched group then 2 example generation Wrist fracture, 5 example compression fracture of lumbar vertebra, 4 example radius far-end fractures.
Treatment prolapse of lumbar intervertebral disc, osteoporosis, the medicine of cervical spondylosis of the present invention, through China Academy Of Traditional Chinese Medicine Traditional Chinese Medicine Research Institute's animal prerun, use to female mice gastric infusion 7 weeks, test shows to make castration mouse phosphatase acid serum activity significantly reduce, serum inorganic phosphorus content significantly raises, femur length can be reduced simultaneously, increase femur transverse diameter.
Detailed description of the invention
Embodiment 1:
A kind of medicine treating prolapse of lumbar intervertebral disc, osteoporosis, cervical spondylosis, is formed (unit, gram) by following raw material:
Radix Angelicae Sinensis 10, Rhizoma Chuanxiong 10, the Radix Paeoniae Alba 10, Radix Puerariae 15, Ramulus Cinnamomi 6, Pheretima 15, the Radix Astragali 15, Radix Pseudostellariae 15, Rhizoma Cibotii 15, Herba Epimedii 15, Rhizoma Dioscoreae 15, Flos Carthami 5；
Its preparation method is: make granule or decoction.
Embodiment 2:
A kind of medicine treating prolapse of lumbar intervertebral disc, osteoporosis, cervical spondylosis, is formed (unit, gram) by following raw material:
Radix Angelicae Sinensis 8, Rhizoma Chuanxiong 12, the Radix Paeoniae Alba 9, Radix Puerariae 13, Ramulus Cinnamomi 6, Pheretima 13, the Radix Astragali 15, Radix Pseudostellariae 16, Rhizoma Cibotii 16, Herba Epimedii 14, Rhizoma Dioscoreae 15, Flos Carthami 4；
Its preparation method is: make granule or decoction.
Claims (1)
1. the medicine treating prolapse of lumbar intervertebral disc, osteoporosis, cervical spondylosis, it is characterised in that: it is made up of following weight parts raw material: Radix Angelicae Sinensis 8-10, Rhizoma Chuanxiong 10-12, Radix Paeoniae Alba 8-10, Radix Puerariae 13-15, Ramulus Cinnamomi 5-6, Pheretima 12-15, Radix Astragali 13-15, Radix Pseudostellariae 12-15, Rhizoma Cibotii 15-16, Herba Epimedii 14-15, Rhizoma Dioscoreae 15-16, Flos Carthami 4-5；
Its preparation method is, chooses raw material by above-mentioned composition, screens, cleans, concocts, is dried, pulverizes, sieves, and makes granule or decoction.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610336320.3A CN105853668A (en) | 2016-05-20 | 2016-05-20 | Medicament for treating lumbar disc herniation, osteoporosis and cervical spondylosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610336320.3A CN105853668A (en) | 2016-05-20 | 2016-05-20 | Medicament for treating lumbar disc herniation, osteoporosis and cervical spondylosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105853668A true CN105853668A (en) | 2016-08-17 |
Family
ID=56634421
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610336320.3A Pending CN105853668A (en) | 2016-05-20 | 2016-05-20 | Medicament for treating lumbar disc herniation, osteoporosis and cervical spondylosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105853668A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114288374A (en) * | 2021-12-28 | 2022-04-08 | 云南琼月企业管理有限公司 | Herbaceous plant preparation for treating blood stasis type cervical and lumbar diseases |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1583069A (en) * | 2004-06-03 | 2005-02-23 | 陈根生 | Medicine for osteoporosis |
| CN103417742A (en) * | 2012-05-16 | 2013-12-04 | 刘家坤 | Traditional Chinese medicine for curing cervical spondylosis and lumbar intervertebral disc hernia |
-
2016
- 2016-05-20 CN CN201610336320.3A patent/CN105853668A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1583069A (en) * | 2004-06-03 | 2005-02-23 | 陈根生 | Medicine for osteoporosis |
| CN103417742A (en) * | 2012-05-16 | 2013-12-04 | 刘家坤 | Traditional Chinese medicine for curing cervical spondylosis and lumbar intervertebral disc hernia |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114288374A (en) * | 2021-12-28 | 2022-04-08 | 云南琼月企业管理有限公司 | Herbaceous plant preparation for treating blood stasis type cervical and lumbar diseases |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102872299B (en) | Medicine compound for treating osteoporosis and osteoporosis fracture | |
| CN102078482B (en) | Traditional Chinese medicine combination for treating bone injury and fracture and preparation method of the same | |
| CN100361704C (en) | Medicated wine for treating rheumatosis and osteoarthropathy | |
| CN101284105A (en) | Thrombolysis lipid-lowering pellet for curing cardio-cerebrovascular disease | |
| CN101766775A (en) | Medicine for treating lumbar disc herniation and osteoproliferation | |
| CN104147577A (en) | Plaster used for promoting generation of bone callus and treating fracture | |
| CN104288470A (en) | Traditional Chinese medicine for treating cervical spondylosis | |
| CN101607015A (en) | A kind of Chinese medicine composition for the treatment of ischemic necrosis of femoral head | |
| CN103893380A (en) | Traditional Chinese medicinal preparation for treating vertebral hyperosteogeny | |
| CN103041089A (en) | Chinese herbal medicine for lowering lipid and dissolving thrombus | |
| CN102836299B (en) | Kidney tonifying and pain relieving pill for treating ankylosing spondylitis | |
| CN105031013A (en) | Medicine for treating lumbar vertebrae bone hyperplasia and preparation method thereof | |
| CN105853668A (en) | Medicament for treating lumbar disc herniation, osteoporosis and cervical spondylosis | |
| CN103550383A (en) | Traditional Chinese medicine composition for treating cervical spondylosis | |
| CN102836309B (en) | Sinew and bone joining pill for treating fracture | |
| CN103720847A (en) | Formula of hyperosteogeny treatment emplastrum | |
| CN103536671B (en) | Drug for treating ischialgia | |
| CN103191315B (en) | Traditional Chinese medicine for treating postmenopausal osteoporosis | |
| CN105998217A (en) | Traditional Chinese medicine composition for treating cervical spondylosis and preparation method | |
| CN102836276B (en) | Bone spur softening pill for treating osteoarthritis | |
| CN104826026A (en) | Medicine for treating middle and later-period femoral head necrosis caused by liver and kidney deficiency and intermin-gled phlegm and blood stasis | |
| CN104740003A (en) | Traditional Chinese medicine for treating lumbar disc herniation | |
| CN103860763A (en) | Chinese patent medicine for treating osteoarthropathy | |
| CN104225112A (en) | Traditional Chinese medicinal composition for curing osteoarthritis | |
| CN106166275A (en) | A kind of decoction medicine treating chronic cervical syndrome and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160817 |
|
| WD01 | Invention patent application deemed withdrawn after publication |